手法を比較
選択した手法を並べて確認できます。異なる行はハイライト表示されます。
| ワクチン信頼性尺度× | COVID-19不安尺度 (CAS)× | |
|---|---|---|
| 分野 | 公衆衛生学 | 公衆衛生学 |
| 系統 | Process / pipeline | Process / pipeline |
| 提唱年≠ | 2015 | 2020 |
| 提唱者≠ | WHO SAGE Working Group on Vaccine Hesitancy | Lipp et al. |
| 種類 | Self-report | Self-report |
| 原典≠ | World Health Organization. (2015). Vaccine hesitancy: A growing challenge for immunization programmes. WHO SAGE Working Group on Vaccine Hesitancy. Geneva: WHO. link ↗ | Lipp, A., Fazio, S., & Cohen, S. (2020). COVID-19 anxiety in the United States. International Journal of Mental Health and Addiction, 20(3), 1234–1248. link ↗ |
| 別名≠ | VCS, WHO Vaccination Confidence Scale | CAS |
| 関連 | 3 | 3 |
| 概要≠ | The WHO Vaccination Confidence Scale (VCS) is a multi-domain instrument measuring three conceptually distinct dimensions of vaccine hesitancy: Confidence (trust in vaccine safety and effectiveness), Complacency (perceived need for vaccination), and Convenience (accessibility and practical barriers). Developed by the WHO SAGE Working Group on Vaccine Hesitancy in 2015, it has become the international standard for measuring determinants of vaccination decisions across diverse populations and pathogen contexts. | The COVID-19 Anxiety Scale (CAS) is a brief, self-administered instrument designed to assess anxiety symptoms specifically related to the COVID-19 pandemic. Developed by Lipp and colleagues in 2020, it captures worry about infection, social isolation, and pandemic-related uncertainties. The scale is widely used in epidemiological surveys and clinical research to identify individuals experiencing pandemic-related anxiety requiring intervention. |
| ScholarGateデータセット ↗ |
|
|